ZA917148B - Mometasone furoate monohydrate,process for making same and pharmaceutical compositions - Google Patents

Mometasone furoate monohydrate,process for making same and pharmaceutical compositions

Info

Publication number: ZA917148B
Authority: ZA; South Africa
Prior art keywords: pharmaceutical compositions; mometasone furoate; making same; furoate monohydrate; monohydrate
Prior art date: 1990-09-10

Application number

ZA917148A

Other languages

English (en)

Inventor

Pui-Ho Yuen

Yuen Pui-Ho

Charles Eckhart

Eckhart Charles

Teresa Etlinger

Etlinger Teresa

Nancy Levine

Levine Nancy

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-09-10

Filing date

1991-09-09

Publication date

1992-08-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24320279&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA917148(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-09-09 Application filed by Schering Corp filed Critical Schering Corp

1992-08-26 Publication of ZA917148B publication Critical patent/ZA917148B/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose

Landscapes

Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Rheumatology (AREA)
General Chemical & Material Sciences (AREA)
Pain & Pain Management (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)

ZA917148A 1990-09-10 1991-09-09 Mometasone furoate monohydrate,process for making same and pharmaceutical compositions ZA917148B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US58023990A	1990-09-10	1990-09-10

Publications (1)

Publication Number	Publication Date
ZA917148B true ZA917148B (en)	1992-08-26

Family

ID=24320279

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA917148A ZA917148B (en)	1990-09-10	1991-09-09	Mometasone furoate monohydrate,process for making same and pharmaceutical compositions

Country Status (35)

Country	Link
US (1)	US6180781B1 (es)
EP (1)	EP0548114B1 (es)
JP (1)	JPH0725789B2 (es)
KR (1)	KR960013445B1 (es)
CN (1)	CN1030920C (es)
AT (1)	ATE113604T1 (es)
AU (1)	AU663471B2 (es)
BG (1)	BG60755B2 (es)
CA (1)	CA2091360C (es)
CZ (1)	CZ281318B6 (es)
DE (2)	DE69104991T2 (es)
DK (1)	DK0548114T5 (es)
EE (1)	EE02962B1 (es)
ES (1)	ES2065701T3 (es)
FI (1)	FI111078B (es)
HK (1)	HK185996A (es)
HR (1)	HRP920383B1 (es)
HU (1)	HU213401B (es)
IE (1)	IE67056B1 (es)
IL (1)	IL99437A (es)
LU (1)	LU90366I2 (es)
MX (2)	MX9203396A (es)
MY (1)	MY106644A (es)
NL (1)	NL980012I2 (es)
NO (1)	NO300548B1 (es)
NZ (1)	NZ239711A (es)
OA (1)	OA09772A (es)
PH (1)	PH30443A (es)
PL (1)	PL165803B1 (es)
PT (1)	PT98905B (es)
SI (1)	SI9111497A (es)
TW (2)	TW272195B (es)
WO (1)	WO1992004365A1 (es)
YU (1)	YU48666B (es)
ZA (1)	ZA917148B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU213401B (en) *	1990-09-10	1997-06-30	Schering Corp	Process for producing mometasone furoate monohydrate and pharmaceutical composition containing it
PE44995A1 (es) *	1994-01-27	1995-12-18	Schering Corp	Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5837699A (en)	1994-01-27	1998-11-17	Schering Corporation	Use of mometasone furoate for treating upper airway passage diseases
US5886200A (en) *	1996-07-01	1999-03-23	Schering Corporation	Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
US5976573A (en)	1996-07-03	1999-11-02	Rorer Pharmaceutical Products Inc.	Aqueous-based pharmaceutical composition
CN1059476C (zh) *	1996-08-21	2000-12-13	邓维鹏	金黄色铝合金硒盐电解着色方法
CA2305256C (en) *	1997-10-09	2005-05-17	Schering Corporation	Mometasone furoate suspensions for nebulization
US6187765B1 (en) *	1997-10-09	2001-02-13	Schering Corporation	Mometasone furoate suspensions for nebulization
MY133181A (en) *	1998-09-10	2007-10-31	Schering Corp	Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
GB0207906D0 (en) *	2002-04-05	2002-05-15	3M Innovative Properties Co	Formoterol and mometasone aerosol formulations
US7811606B2 (en)	2003-04-16	2010-10-12	Dey, L.P.	Nasal pharmaceutical formulations and methods of using the same
US9808471B2 (en)	2003-04-16	2017-11-07	Mylan Specialty Lp	Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en)	2003-04-16	2014-12-16	Mylan Pharmaceuticals Inc.	Formulations and methods for treating rhinosinusitis
NZ545748A (en) *	2003-08-29	2010-03-26	Ranbaxy Lab Ltd	Isoxazoline derivatives as inhibitors of phosphodiesterase type-IV
WO2005051931A2 (en) *	2003-11-26	2005-06-09	Ranbaxy Laboratories Limited	Phosphodiesterase inhibitors
US7491725B2 (en)	2004-02-06	2009-02-17	Bristol-Myers Squibb Company	Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
WO2007031838A1 (en)	2005-09-16	2007-03-22	Ranbaxy Laboratories Limited	Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US20070099883A1 (en) *	2005-10-07	2007-05-03	Cheryl Lynn Calis	Anhydrous mometasone furoate formulation
WO2007045980A1 (en) *	2005-10-19	2007-04-26	Ranbaxy Laboratories Limited	Compositions of phosphodiesterase type iv inhibitors
AU2006305619A1 (en)	2005-10-19	2007-04-26	Ranbaxy Laboratories Limited	Pharmaceutical compositions of muscarinic receptor antagonists
CN100389121C (zh) *	2005-12-09	2008-05-21	天津药业集团有限公司	糠酸莫美他松中间体21-羟的制备方法
CN100436473C (zh) *	2005-12-09	2008-11-26	天津药业集团有限公司	糠酸莫美他松中间体21-酯及制法
DE102006034883A1 (de) *	2006-07-25	2008-01-31	Hermal Kurt Herrmann Gmbh & Co. Ohg	Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
MX2009003100A (es) *	2006-09-22	2009-05-11	Ranbaxy Lab Ltd	Inhibidores de fosfodiesterasa tipo iv.
US20100029728A1 (en) *	2006-09-22	2010-02-04	Ranbaxy Laboratories Limited	Phosphodiesterase inhibitors
EP1958947A1 (en)	2007-02-15	2008-08-20	Ranbaxy Laboratories Limited	Inhibitors of phosphodiesterase type 4
EP2124943A1 (en) *	2007-03-14	2009-12-02	Ranbaxy Laboratories Limited	Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors
MX2009009793A (es)	2007-03-14	2009-10-16	Ranbaxy Lab Ltd	Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa.
EP2111861A1 (en)	2008-04-21	2009-10-28	Ranbaxy Laboratories Limited	Compositions of phosphodiesterase type IV inhibitors
LT2435025T (lt)	2009-05-29	2016-09-26	Pearl Therapeutics, Inc.	Veikliosios medžiagos tiekimas per kvėpavimo takus
US8815258B2 (en) *	2009-05-29	2014-08-26	Pearl Therapeutics, Inc.	Compositions, methods and systems for respiratory delivery of two or more active agents
PT105058B (pt)	2010-04-21	2013-04-17	Hovione Farmaciencia S A	Processo para processamento de partículas de ingredientes activos farmacêuticos
JP6454323B2 (ja)	2013-03-15	2019-01-16	パールセラピューティクス，インコーポレイテッド	粒子状結晶性材料のコンディショニングのための方法及びシステム
CN107266518B (zh) *	2016-04-08	2021-03-30	天津金耀集团有限公司	一种糠酸莫米松晶型及其制备方法
CN107260671B (zh) *	2016-04-08	2021-03-26	天津金耀集团有限公司	一种糠酸莫米松混悬鼻喷剂组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3260474D1 (en) *	1981-02-02	1984-09-06	Schering Corp	Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
US4783444A (en)	1984-09-17	1988-11-08	Schering Corporation	Antiglaucoma compositions and methods
US4808610A (en) *	1986-10-02	1989-02-28	Schering Corporation	Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) *	1987-05-21	1988-10-04	Schering Corporation	Steroid lotion
HU213401B (en) *	1990-09-10	1997-06-30	Schering Corp	Process for producing mometasone furoate monohydrate and pharmaceutical composition containing it

1991
- 1991-09-06 HU HU9300685A patent/HU213401B/hu unknown
- 1991-09-06 ES ES91915453T patent/ES2065701T3/es not_active Expired - Lifetime
- 1991-09-06 WO PCT/US1991/006249 patent/WO1992004365A1/en active IP Right Grant
- 1991-09-06 PL PL91298223A patent/PL165803B1/pl unknown
- 1991-09-06 KR KR1019930700702A patent/KR960013445B1/ko not_active IP Right Cessation
- 1991-09-06 DE DE69104991T patent/DE69104991T2/de not_active Expired - Lifetime
- 1991-09-06 MX MX9203396A patent/MX9203396A/es unknown
- 1991-09-06 DE DE1991604991 patent/DE19875032I2/de active Active
- 1991-09-06 CZ CZ93383A patent/CZ281318B6/cs not_active IP Right Cessation
- 1991-09-06 EP EP91915453A patent/EP0548114B1/en not_active Expired - Lifetime
- 1991-09-06 AT AT91915453T patent/ATE113604T1/de active
- 1991-09-06 AU AU84974/91A patent/AU663471B2/en not_active Expired
- 1991-09-06 IL IL9943791A patent/IL99437A/en not_active IP Right Cessation
- 1991-09-06 CA CA002091360A patent/CA2091360C/en not_active Expired - Lifetime
- 1991-09-06 DK DK91915453.4T patent/DK0548114T5/da active
- 1991-09-06 JP JP3514768A patent/JPH0725789B2/ja not_active Expired - Lifetime
- 1991-09-09 IE IE315591A patent/IE67056B1/en not_active IP Right Cessation
- 1991-09-09 PH PH43072A patent/PH30443A/en unknown
- 1991-09-09 MY MYPI91001630A patent/MY106644A/en unknown
- 1991-09-09 ZA ZA917148A patent/ZA917148B/xx unknown
- 1991-09-09 SI SI9111497A patent/SI9111497A/sl unknown
- 1991-09-09 MX MX9100990A patent/MX9100990A/es unknown
- 1991-09-09 PT PT98905A patent/PT98905B/pt not_active IP Right Cessation
- 1991-09-09 TW TW083106101A patent/TW272195B/zh not_active IP Right Cessation
- 1991-09-09 TW TW080107102A patent/TW229208B/zh not_active IP Right Cessation
- 1991-09-09 NZ NZ239711A patent/NZ239711A/en not_active IP Right Cessation
- 1991-09-09 YU YU149791A patent/YU48666B/sh unknown
- 1991-09-10 CN CN91108910A patent/CN1030920C/zh not_active Expired - Lifetime
1992
- 1992-09-21 HR HRP-1497/91A patent/HRP920383B1/xx not_active IP Right Cessation
1993
- 1993-02-26 NO NO930693A patent/NO300548B1/no not_active IP Right Cessation
- 1993-03-09 FI FI931031A patent/FI111078B/fi not_active IP Right Cessation
- 1993-03-09 OA OA60348A patent/OA09772A/en unknown
1994
- 1994-02-24 BG BG98564A patent/BG60755B2/bg unknown
- 1994-11-21 EE EE9400388A patent/EE02962B1/xx unknown
1995
- 1995-04-17 US US08/422,479 patent/US6180781B1/en not_active Expired - Lifetime
1996
- 1996-10-03 HK HK185996A patent/HK185996A/xx not_active IP Right Cessation
1998
- 1998-03-12 NL NL980012C patent/NL980012I2/nl unknown
1999
- 1999-03-05 LU LU90366C patent/LU90366I2/xx unknown

Also Published As

Publication number	Publication date
NZ239711A (en)	1992-09-25
DE19875032I2 (de)	2007-04-19
HRP920383B1 (en)	2000-04-30
NO930693D0 (no)	1993-02-26
YU149791A (sh)	1994-01-20
PH30443A (en)	1997-05-09
IE67056B1 (en)	1996-02-21
SI9111497A (sl)	1998-04-30
HU9300685D0 (en)	1993-06-28
CA2091360C (en)	1997-04-08
WO1992004365A1 (en)	1992-03-19
IL99437A (en)	1995-05-29
HU213401B (en)	1997-06-30
DK0548114T5 (da)	1995-01-30
IL99437A0 (en)	1992-08-18
FI931031A0 (fi)	1993-03-09
MX9203396A (es)	1992-07-31
AU8497491A (en)	1992-03-30
DE69104991T2 (de)	1995-04-20
KR960013445B1 (ko)	1996-10-05
DE69104991D1 (de)	1994-12-08
IE913155A1 (en)	1992-03-11
TW229208B (es)	1994-09-01
CZ38393A3 (en)	1994-01-19
YU48666B (sh)	1999-06-15
NL980012I1 (nl)	1998-05-06
CN1059911A (zh)	1992-04-01
JPH05506667A (ja)	1993-09-30
OA09772A (en)	1993-11-30
HUT64361A (en)	1993-12-28
MX9100990A (es)	1992-05-04
NO300548B1 (no)	1997-06-16
CA2091360A1 (en)	1992-03-11
LU90366I2 (fr)	1999-05-05
FI931031A (fi)	1993-03-09
FI111078B (fi)	2003-05-30
PT98905A (pt)	1992-09-30
HK185996A (en)	1996-10-11
PL165803B1 (pl)	1995-02-28
CN1030920C (zh)	1996-02-07
JPH0725789B2 (ja)	1995-03-22
MY106644A (en)	1995-07-31
AU663471B2 (en)	1995-10-12
TW272195B (es)	1996-03-11
EP0548114B1 (en)	1994-11-02
EE02962B1 (et)	1997-02-17
ES2065701T3 (es)	1995-02-16
CZ281318B6 (cs)	1996-08-14
BG60755B2 (bg)	1996-02-29
EP0548114A1 (en)	1993-06-30
US6180781B1 (en)	2001-01-30
NO930693L (no)	1993-02-26
HRP920383A2 (en)	1998-06-30
NL980012I2 (nl)	2004-11-01
PT98905B (pt)	1998-08-31
ATE113604T1 (de)	1994-11-15

Publication	Publication Date	Title
TW229208B (es)	1994-09-01
UA34428C2 (uk)	2001-03-15	Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
ZA832135B (en)	1984-11-28	Norscopine ethers,processes for their preparation and pharmaceutical compositions thereof
NZ240230A (en)	1993-01-27	Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
ES8307794A1 (es)	1983-08-01	Un procedimiento para la preparacion de agentes antifugicos triazolicos.
IL94433A0 (en)	1991-03-10	Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
IL117091A0 (en)	1996-06-18	Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
ZA851552B (en)	1985-11-27	Benzisoselenazolethiones,processes for their preparation and pharmaceutical products containing these compounds
IT8219908A0 (it)	1982-03-02	Derivati di ferro biodisponibile esenti da gastrolesivita',procedimento di preparazione e relative composizioni farmaceutiche.
CA2152771A1 (en)	1996-01-29	7-o-ethers of taxane derivatives
DE3063905D1 (en)	1983-07-28	Compounds having antitumour properties, process for their preparation, these compounds for use as antitumour agents and pharmaceutical compositions containing them
ES477562A1 (es)	1979-10-16	Procedimiento para preparar derivados de alcanolamina.
ES8504166A1 (es)	1984-07-16	Un metodo de preparar derivados de 6,11-dihidrodibenz(b,e) oxepina.
IL66192A (en)	1985-08-30	Albomycin derivatives,their production and pharmaceutical compositions containing them
ZA912180B (en)	1992-10-28	Novel compounds.cephalosporins,process for their preparation and pharmaceutical compositions containing them
JO1711B1 (en)	1992-12-15	Therapeutic agents
IT1255696B (it)	1995-11-10	Composto con attivita' vasodilatatrice procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
IT1269740B (it)	1997-04-15	Derivati di combretastatine ad attivita' anti-tumorale e procedimento per la loro preparazione